您要查找的是不是：
- Overweight women who undergo axillary lymph node dissection are more likely to develop lymphedema. 超重的妇女在进行腋窝淋巴结清扫后更容易产生淋巴水肿。
- Pathological examinations: In BCT group, the average of axillary lymph node was 9.6 and 3 case was positive (20.0%). 1)病理检查:保乳手术组手术标本石蜡病理检查各切缘均无癌浸润;腋窝淋巴结平均检出9.;6枚;阳性3例(20
- Oerweight women who undergo axillary lymph node dissection are more likely to deelop lymphedema. 超重的妇女在进行腋窝淋巴结清扫后更容易产生淋巴水肿。
- Conclusion Anterior axillary lymph node part is the good donor area for the vascular lymph node graft. 结论腋窝淋巴前群为吻合血管淋巴结移植的理想供区。
- Objective To study the precision of axillary lymph nodal metastasis by sentinel lymph node(SLN) biopsy for brest cancer. 目的通过对乳腺癌前哨淋巴结(SLN)活检,探讨其对腋淋巴结(ALN)转移情况预测的准确性。
- Surgery was performed in 32 cases (16 mastectomies and 16 breast conseration surgeries with axillary lymph node dissection). 32例进行了外科手术（16例乳房切除术、16例保存乳房外科手术并腋窝淋巴结清除）。
- The blood microvessel density, as a significant indictor to evaluate the status of axillary lymph node and prognosis of patient, is gradually accepted. 微血管密度作为预测腋 窝淋巴结状态以及判断患者预后的一项有价值的指标已逐渐为大家所接 受。
- Objective To analyze the value of 18F-FDG coincidence SPECT detection in the diagnosis of breast cancer and evaluate axillary lymph node metastasis. 摘要目的探讨18F-FDG符合线路SPECT检查对于乳腺癌诊断和淋巴结转移探查价值。
- We believe that this technique may replace axillary lymph node dissection for breast cancer patients with negative axillae in the future. 我们相信在将来治疗腋淋巴结阴性的乳腺癌中，这一技术可以免除患者接受不必要的腋淋巴结清扫术。
- We report a52- year-old male with preoperative physical and mammographic findings highly suggestive of breast carcinoma with axillary lymph node metastasis. 摘要我们报告一五十二岁男性病例，术前之临床及乳房摄影表现高度怀疑为乳癌并腋下淋巴结转移。
- Objective To explore the diagnostic value of 18 F-fluorodeoxyglucose (FDG) dual-head coincidence (DHC) imaging for detecting breast cancer and axillary lymph node metastases. 目的 探讨1 8F 脱氧葡萄糖 (FDG)符合线路 (DHC)显像诊断原发性乳腺癌及监测腋窝淋巴结转移的价值。
- The expression of uPA were related to axillary lymph node metastasis and TNM stage,and the expressions of uPA were not related to age,tumor size and the histologic grade. 乳腺癌组织中uPA的阳性表达与腋窝淋巴结转移和临床TNM分期有关; uPA的阳性表达与年龄、肿瘤大小、病理分级无关。
- Abdominal CT is done if patients have abnormal liver function results, hepatomegaly, or locally advanced cancer with or without axillary lymph node involvement. 如病人出现下列情况则应作腹部CT：肝功异常、肝肿大、局部晚期癌症伴或无腋淋巴结受累。
- HAI J,HUANG JH,SHU HP,et al.Relationship of micrometastasis in axillary lymph node and sirvivin gene in breast tissue[J].China Journal of Modern Medicine,2005,15(17):2612-2614. [2]海健;黄俊辉;舒衡平;等.;乳腺癌腋淋巴结微小转移与癌组织Survivin基因表达关系的研究[J]
- We report a 52-year-old male with preoperative physical and mammographic findings highly suggestive of breast carcinoma with axillary lymph node metastasis. 我们报告一五十二岁男性病例，术前之临床及乳房摄影表现高度怀疑为乳癌并腋下淋巴结转移。
- The positive expression rate of nm23 H 1 was 21.7% (13/60) in 60 PBC. nm23 H 1 expression in PBC was negatively correlated with tumor size,clinical stage and axillary lymph node me tastasis. nm2 3 H1基因蛋白在乳腺癌组织中表达阳性率为 2 1.;7%25 (13/ 6 0 );nm2 3 H1蛋白表达与肿瘤大小、临床分期和腋淋巴结转移呈负相关。
- BRCA1 expression was correlated with other molecular biological parameters including P53, ER, C-erbB-2, Ki67 and some prognostic parameters including age, histological grade, tumor size, axillary lymph node status and prognosis. 分析BRCAl基因的表达与一些生物学标志物(P53、ER、C-erbB-2、Ki67)及一些临床病理学参数(发病年龄、瘤体大小，淋巴转移情况、组织学类型、组织学分级和预后)间的关系。
- In patients with breast cancer, the level of SDF-1 protein in axillary lymph node (ALN) metastasis positive patients was significantly higher than that in ALN metastasis negative ones （P=0.036）. 而在乳腺癌患者中，已有腋窝淋巴结转移者的SDF-1蛋白表达水平又高于无腋窝淋巴结转移者（P=0.;036）。
- Sometimes, mammary ministry bump is very small even when untouchability arrives, already produced axillary lymph node to transfer namely, accordingly, axillary examination is very important. 有时，乳房部肿块很小甚至不能触摸到时，即已发生了腋窝淋巴结转移，因此，腋窝的检查非常重要。
- Prognostic indictor analysis showed that only axillary lymph node status proved to have a prognostic impact.Tumor size,age did not show any prognostic influence.Because of less cases,we ca... 在预后指标单因素分析中，发现腋淋巴结转移为唯一的临床预后指标，而肿瘤大小、年龄等因素都对预后没有影响。
